{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:06:40Z","timestamp":1792069600557,"version":"4.4.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Mol Cell Biol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/nrm2101","type":"journal-article","created":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T06:18:54Z","timestamp":1169619534000},"page":"101-112","source":"Crossref","is-referenced-by-count":4322,"title":["Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid \u03b2-peptide"],"prefix":"10.1038","volume":"8","author":[{"given":"Christian","family":"Haass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrm2101_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","volume":"18","author":"T Gasser","year":"2005","unstructured":"Gasser, T. Genetics of Parkinson's disease. Curr. Opin. Neurol. 18, 363\u2013369 (2005).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrm2101_CR2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"BFnrm2101_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1471-4159.2002.01020.x","volume":"82","author":"PJ Kahle","year":"2002","unstructured":"Kahle, P. J., Haass, C., Kretzschmar, H. A. & Neumann, M. Structure\/function of \u03b1-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases. J. Neurochem. 82, 449\u2013457 (2002).","journal-title":"J. Neurochem."},{"key":"BFnrm2101_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"BFnrm2101_CR5","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M. et al. Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879\u2013884 (1998).","journal-title":"Am. J. Pathol."},{"key":"BFnrm2101_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/364362c0","volume":"364","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362 (1993).","journal-title":"Nature"},{"key":"BFnrm2101_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.8351519","volume":"261","author":"HX Deng","year":"1993","unstructured":"Deng, H. X. et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047\u20131051 (1993).","journal-title":"Science"},{"key":"BFnrm2101_CR8","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971\u2013983 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"BFnrm2101_CR9","first-page":"146","volume":"64","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer, A. \u00dcber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatrie Psychisch-Gerichtl. Med. 64, 146\u2013148 (1907).","journal-title":"Allg. Z. Psychiatrie Psychisch-Gerichtl. Med."},{"key":"BFnrm2101_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner, G. G. & Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885\u2013890 (1984).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrm2101_CR11","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245\u20134249 (1985).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR12","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal, I. et al. Abnormal phosphorylation of the microtubule-associated protein \u03c4 (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913\u20134917 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR13","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","volume":"83","author":"KS Kosik","year":"1986","unstructured":"Kosik, K. S., Joachim, C. L. & Selkoe, D. J. Microtubule-associated protein \u03c4 (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl Acad. Sci. USA 83, 4044\u20134048 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/oxfordjournals.jbchem.a135625","volume":"99","author":"N Nukina","year":"1986","unstructured":"Nukina, N. & Ihara, Y. One of the antigenic determinants of paired helical filaments is related to \u03c4 protein. J. Biochem. 99, 1541\u20131544 (1986).","journal-title":"J. Biochem."},{"key":"BFnrm2101_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","volume":"122","author":"GG Glenner","year":"1984","unstructured":"Glenner, G. G. & Wong, C. W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131\u20131135 (1984).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrm2101_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/brain\/92.1.147","volume":"92","author":"MI Olson","year":"1969","unstructured":"Olson, M. I. & Shaw, C. M. Presenile dementia and Alzheimer's disease in mongolism. Brain 92, 147\u2013156 (1969).","journal-title":"Brain"},{"key":"BFnrm2101_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733\u2013736 (1987).","journal-title":"Nature"},{"key":"BFnrm2101_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.2111584","volume":"248","author":"E Levy","year":"1990","unstructured":"Levy, E. et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124\u20131126 (1990).","journal-title":"Science"},{"key":"BFnrm2101_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704\u2013706 (1991).","journal-title":"Nature"},{"key":"BFnrm2101_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin, M. C. et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the \u03b2-amyloid precursor protein gene. Nature 353, 844\u2013846 (1991).","journal-title":"Nature"},{"key":"BFnrm2101_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan, M. et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of \u03b2-amyloid. Nature Genet. 1, 345\u2013347 (1992).","journal-title":"Nature Genet."},{"key":"BFnrm2101_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe, D. J. The molecular pathology of Alzheimer's disease. Neuron 6, 487\u2013498 (1991).","journal-title":"Neuron"},{"key":"BFnrm2101_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992). References 22 and 23 set out the amyloid cascade hypothesis, for which strong experimental evidence is now accumulating.","journal-title":"Science"},{"key":"BFnrm2101_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"BFnrm2101_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass, C. et al. Amyloid \u03b2-peptide is produced by cultured cells during normal metabolism. Nature 359, 322\u2013325 (1992).","journal-title":"Nature"},{"key":"BFnrm2101_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","volume":"359","author":"P Seubert","year":"1992","unstructured":"Seubert, P. et al. Isolation and quantification of soluble Alzheimer's \u03b2-peptide from biological fluids. Nature 359, 325\u2013327 (1992).","journal-title":"Nature"},{"key":"BFnrm2101_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/science.1439760","volume":"258","author":"M Shoji","year":"1992","unstructured":"Shoji, M. et al. Production of the Alzheimer amyloid \u03b2-protein by normal proteolytic processing. Science 258, 126\u2013129 (1992).","journal-title":"Science"},{"key":"BFnrm2101_CR28","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1073\/pnas.90.5.2092","volume":"90","author":"J Busciglio","year":"1993","unstructured":"Busciglio, J., Gabuzda, D. H., Matsudaira, P. & Yankner, B. A. Generation of \u03b2-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 2092\u20132096 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","volume":"23","author":"C Haass","year":"2004","unstructured":"Haass, C. Take five-BACE and the \u03b3-secretase quartet conduct Alzheimer's amyloid \u03b2-peptide generation. EMBO J. 23, 483\u2013488 (2004). A review on APP processing by \u03b2- and \u03b3-secretase.","journal-title":"EMBO J."},{"key":"BFnrm2101_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0092-8674(00)80675-3","volume":"100","author":"MS Brown","year":"2000","unstructured":"Brown, M. S., Ye, J., Rawson, R. B. & Goldstein, J. L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391\u2013398 (2000).","journal-title":"Cell"},{"key":"BFnrm2101_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0962-8924(02)00041-7","volume":"13","author":"A Weihofen","year":"2003","unstructured":"Weihofen, A. & Martoglio, B. Intramembrane-cleaving proteases: controlled liberation of functional proteins and peptides from membranes. Trends Cell Biol. 13, 71\u201378 (2003).","journal-title":"Trends Cell Biol."},{"key":"BFnrm2101_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/dbio.2000.9960","volume":"228","author":"JS Mumm","year":"2000","unstructured":"Mumm, J. S. & Kopan, R. Notch signaling: from the outside in. Dev. Biol. 228, 151\u2013165 (2000).","journal-title":"Dev. Biol."},{"key":"BFnrm2101_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and \u03b3-secretase activity. Nature 398, 513\u2013517 (1999).","journal-title":"Nature"},{"key":"BFnrm2101_CR34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/35041097","volume":"2","author":"H Steiner","year":"2000","unstructured":"Steiner, H. et al. Glycine 384 is required for presenilin-1 function and is conserved in polytopic bacterial aspartyl proteases. Nature Cell Biol. 2, 848\u2013851 (2000).","journal-title":"Nature Cell Biol."},{"key":"BFnrm2101_CR35","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1073\/pnas.1037392100","volume":"100","author":"WT Kimberly","year":"2003","unstructured":"Kimberly, W. T. et al. \u03b3-Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl Acad. Sci. USA 100, 6382\u20136387 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR36","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature01506","volume":"422","author":"N Takasugi","year":"2003","unstructured":"Takasugi, N. et al. The role of presenilin cofactors in the \u03b3-secretase complex. Nature 422, 438\u2013441 (2003).","journal-title":"Nature"},{"key":"BFnrm2101_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncb960","volume":"5","author":"D Edbauer","year":"2003","unstructured":"Edbauer, D. et al. Reconstitution of \u03b3-secretase activity. Nature Cell Biol. 5, 486\u2013488 (2003).","journal-title":"Nature Cell Biol."},{"key":"BFnrm2101_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/embo-reports\/kve180","volume":"2","author":"M Sastre","year":"2001","unstructured":"Sastre, M. et al. Presenilin-dependent \u03b3-secretase processing of \u03b2-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835\u2013841 (2001).","journal-title":"EMBO Rep."},{"key":"BFnrm2101_CR39","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1021\/bi015794o","volume":"41","author":"A Weidemann","year":"2002","unstructured":"Weidemann, A. et al. A novel \u03b5-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41, 2825\u20132835 (2002).","journal-title":"Biochemistry"},{"key":"BFnrm2101_CR40","doi-asserted-by":"publisher","first-page":"35235","DOI":"10.1074\/jbc.C100357200","volume":"276","author":"Y Gu","year":"2001","unstructured":"Gu, Y. et al. Distinct intramembrane cleavage of the \u03b2-amyloid precursor protein family resembling \u03b3-secretase-like cleavage of Notch. J. Biol. Chem. 276, 35235\u201335238 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","volume":"25","author":"Y Qi-Takahara","year":"2005","unstructured":"Qi-Takahara, Y. et al. Longer forms of amyloid \u03b2 protein: implications for the mechanism of intramembrane cleavage by \u03b3-secretase. J. Neurosci. 25, 436\u2013445 (2005).","journal-title":"J. Neurosci."},{"key":"BFnrm2101_CR42","doi-asserted-by":"publisher","first-page":"37689","DOI":"10.1074\/jbc.M507993200","volume":"280","author":"G Zhao","year":"2005","unstructured":"Zhao, G. et al. \u03b3-cleavage is dependent on \u03b6-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain. J. Biol. Chem. 280, 37689\u201337697 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","volume":"56","author":"DW Dickson","year":"1997","unstructured":"Dickson, D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56, 321\u2013339 (1997).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrm2101_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J Naslund","year":"2000","unstructured":"Naslund, J. et al. Correlation between elevated levels of amyloid \u03b2-peptide in the brain and cognitive decline. JAMA 283, 1571\u20131577 (2000).","journal-title":"JAMA"},{"key":"BFnrm2101_CR45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue, L. F. et al. Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853\u2013862 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrm2101_CR46","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C. A. et al. Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860\u2013866 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnrm2101_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1006\/exnr.1999.7085","volume":"158","author":"J Wang","year":"1999","unstructured":"Wang, J., Dickson, D. W., Trojanowski, J. Q. & Lee, V. M. The levels of soluble versus insoluble brain A\u03b2 distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158, 328\u2013337 (1999).","journal-title":"Exp. Neurol."},{"key":"BFnrm2101_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805\u2013810 (2004). Evidence that small, diffusible aggregates of intracellular huntingtin can confer neurotoxicity, perhaps analogously to soluble A\u03b2 oligomers.","journal-title":"Nature"},{"key":"BFnrm2101_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","volume":"15","author":"G Schaffar","year":"2004","unstructured":"Schaffar, G. et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15, 95\u2013105 (2004).","journal-title":"Mol. Cell"},{"key":"BFnrm2101_CR50","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0896-6273(00)81035-1","volume":"24","author":"CJ Cummings","year":"1999","unstructured":"Cummings, C. J. et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879\u2013892 (1999).","journal-title":"Neuron"},{"key":"BFnrm2101_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nn1335","volume":"7","author":"J Tsai","year":"2004","unstructured":"Tsai, J., Grutzendler, J., Duff, K. & Gan, W. B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neurosci. 7, 1181\u20131183 (2004).","journal-title":"Nature Neurosci."},{"key":"BFnrm2101_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267\u2013298 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnrm2101_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/13506129808995290","volume":"5","author":"DB Teplow","year":"1998","unstructured":"Teplow, D. B. Structural and kinetic features of amyloid \u03b2-protein fibrillogenesis. Amyloid 5, 121\u2013142 (1998).","journal-title":"Amyloid"},{"key":"BFnrm2101_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1074-5521(97)90255-6","volume":"4","author":"JD Harper","year":"1997","unstructured":"Harper, J. D., Wong, S. S., Lieber, C. M. & Lansbury, P. T. Observation of metastable A\u03b2 amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119\u2013125 (1997).","journal-title":"Chem. Biol."},{"key":"BFnrm2101_CR55","doi-asserted-by":"publisher","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","volume":"19","author":"DM Hartley","year":"1999","unstructured":"Hartley, D. M. et al. Protofibrillar intermediates of amyloid \u03b2-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876\u20138884 (1999).","journal-title":"J. Neurosci."},{"key":"BFnrm2101_CR56","doi-asserted-by":"publisher","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","volume":"272","author":"DM Walsh","year":"1997","unstructured":"Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M. & Teplow, D. B. Amyloid \u03b2-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364\u201322372 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR57","doi-asserted-by":"publisher","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","volume":"274","author":"DM Walsh","year":"1999","unstructured":"Walsh, D. M. et al. Amyloid \u03b2-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945\u201325952 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1073\/pnas.222681699","volume":"100","author":"G Bitan","year":"2003","unstructured":"Bitan, G. et al. Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways. Proc. Natl Acad. Sci. USA 100, 330\u2013335 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/418291a","volume":"418","author":"HA Lashuel","year":"2002","unstructured":"Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. & Lansbury, P. T. Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291 (2002).","journal-title":"Nature"},{"key":"BFnrm2101_CR60","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR61","doi-asserted-by":"publisher","first-page":"10417","DOI":"10.1073\/pnas.1834302100","volume":"100","author":"Y Gong","year":"2003","unstructured":"Gong, Y. et al. Alzheimer's disease-affected brain: presence of oligomeric A\u03b2 ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA 100, 10417\u201310422 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR62","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne, S. et al. A specific amyloid-\u03b2 protein assembly in the brain impairs memory. Nature 440, 352\u2013357 (2006). Identification of a brain-derived A\u03b2 oligomeric assembly, which impairs memory.","journal-title":"Nature"},{"key":"BFnrm2101_CR63","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","volume":"270","author":"MB Podlisny","year":"1995","unstructured":"Podlisny, M. B. et al. Aggregation of secreted amyloid \u03b2-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270, 9564\u20139570 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR64","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1021\/bi001048s","volume":"39","author":"DM Walsh","year":"2000","unstructured":"Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B. & Selkoe, D. J. The oligomerization of amyloid \u03b2-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831\u201310839 (2000).","journal-title":"Biochemistry"},{"key":"BFnrm2101_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0002-9440(10)65094-8","volume":"155","author":"H Funato","year":"1999","unstructured":"Funato, H., Enya, M., Yoshimura, M., Morishima-Kawashima, M. & Ihara, Y. Presence of sodium dodecyl sulfate-stable amyloid \u03b2-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation. Am. J. Pathol. 155, 23\u201328 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrm2101_CR66","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0002-9440(10)65273-X","volume":"154","author":"M Enya","year":"1999","unstructured":"Enya, M. et al. Appearance of sodium dodecyl sulfate-stable amyloid \u03b2-protein (A\u03b2) dimer in the cortex during aging. Am. J. Pathol. 154, 271\u2013279 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrm2101_CR67","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","volume":"24","author":"T Kawarabayashi","year":"2004","unstructured":"Kawarabayashi, T. et al. Dimeric amyloid \u03b2 protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated \u03c4 accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 24, 3801\u20133809 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrm2101_CR68","doi-asserted-by":"publisher","first-page":"20631","DOI":"10.1074\/jbc.271.34.20631","volume":"271","author":"AE Roher","year":"1996","unstructured":"Roher, A. E. et al. Morphology and toxicity of A\u03b2-(1\u201342) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631\u201320635 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M. et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002). Defines a synaptotoxic function for small, soluble oligomers of secreted A\u03b2 in vivo.","journal-title":"Nature"},{"key":"BFnrm2101_CR70","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925\u2013937 (2003). Demonstrates the effects of A\u03b2 on synaptic function upon the stimulation of neuronal activity.","journal-title":"Neuron"},{"key":"BFnrm2101_CR71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","volume":"572","author":"M Townsend","year":"2006","unstructured":"Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M. & Selkoe, D. J. Effects of secreted oligomers of amyloid \u03b2-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572, 477\u2013492 (2006).","journal-title":"J. Physiol."},{"key":"BFnrm2101_CR72","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nm1234","volume":"11","author":"I Klyubin","year":"2005","unstructured":"Klyubin, I. et al. Amyloid \u03b2 protein immunotherapy neutralizes A\u03b2 oligomers that disrupt synaptic plasticity in vivo. Nature Med. 11, 556\u2013561 (2005). LTP inhibition by soluble oligomers of human A\u03b2 is prevented by active and passive A\u03b2 immunotherapy.","journal-title":"Nature Med."},{"key":"BFnrm2101_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary, J. P. et al. Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function. Nature Neurosci. 8, 79\u201384 (2005).","journal-title":"Nature Neurosci."},{"key":"BFnrm2101_CR74","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito, J. R. et al. Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo. Neuron 48, 913\u2013922 (2005). An in vivo demonstration of the effects of synaptic activity on A\u03b2 levels.","journal-title":"Neuron"},{"key":"BFnrm2101_CR75","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder, E. M. et al. Regulation of NMDA receptor trafficking by amyloid-\u03b2. Nature Neurosci. 8, 1051\u20131058 (2005). A cellular mechanism that describes how A\u03b2 lowers NMDA-evoked currents.","journal-title":"Nature Neurosci."},{"key":"BFnrm2101_CR76","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","volume":"126","author":"B Gong","year":"2006","unstructured":"Gong, B. et al. Ubiquitin hydrolase Uch-L1 rescues \u03b2-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775\u2013788 (2006).","journal-title":"Cell"},{"key":"BFnrm2101_CR77","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann, M. et al. Exogenous induction of cerebral \u03b2-amyloidogenesis is governed by agent and host. Science 313, 1781\u20131784 (2006).","journal-title":"Science"},{"key":"BFnrm2101_CR78","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1212\/01.wnl.0000192103.24796.42","volume":"66","author":"CG Glabe","year":"2006","unstructured":"Glabe, C. G. & Kayed, R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66, S74\u2013S78 (2006).","journal-title":"Neurology"},{"key":"BFnrm2101_CR79","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003). Describes common conformational epitopes on oligomers of completely distinct amyloidogenic proteins.","journal-title":"Science"},{"key":"BFnrm2101_CR80","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel, H. A. et al. \u03b1-Synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol. 322, 1089\u20131102 (2002).","journal-title":"J. Mol. Biol."},{"key":"BFnrm2101_CR81","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Jr. Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 2552\u20132563 (2000).","journal-title":"Biochemistry"},{"key":"BFnrm2101_CR82","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease. Nature Med. 4, 1318\u20131320 (1998).","journal-title":"Nature Med."},{"key":"BFnrm2101_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571\u2013576 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.compbiolchem.2006.01.003","volume":"30","author":"AJ Marchut","year":"2006","unstructured":"Marchut, A. J. & Hall, C. K. Spontaneous formation of annular structures observed in molecular dynamics simulations of polyglutamine peptides. Comput. Biol. Chem. 30, 215\u2013218 (2006).","journal-title":"Comput. Biol. Chem."},{"key":"BFnrm2101_CR85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/13506120410001667872","volume":"11","author":"R Srinivasan","year":"2004","unstructured":"Srinivasan, R., Marchant, R. E. & Zagorski, M. G. ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures. Amyloid 11, 10\u201313 (2004).","journal-title":"Amyloid"},{"key":"BFnrm2101_CR86","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1083\/jcb.118.3.573","volume":"118","author":"H Wille","year":"1992","unstructured":"Wille, H., Drewes, G., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein \u03c4 in vitro. J. Cell. Biol. 118, 573\u2013584 (1992).","journal-title":"J. Cell. Biol."},{"key":"BFnrm2101_CR87","doi-asserted-by":"publisher","first-page":"15712","DOI":"10.1073\/pnas.95.26.15712","volume":"95","author":"P Friedhoff","year":"1998","unstructured":"Friedhoff, P., von Bergen, M., Mandelkow, E. M., Davies, P. & Mandelkow, E. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc. Natl Acad. Sci. USA 95, 15712\u201315717 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR88","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"BFnrm2101_CR89","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.1132341","volume":"314","author":"M Willem","year":"2006","unstructured":"Willem, M. et al. Control of peripheral nerve myelination by the \u03b2-secretase BACE1. Science 314, 664\u2013666 (2006).","journal-title":"Science"},{"key":"BFnrm2101_CR90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk, D. et al. Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173\u2013177 (1999). Initial report of the beneficial effects of A\u03b2 immunotherapy in a transgenic mouse model of AD.","journal-title":"Nature"},{"key":"BFnrm2101_CR91","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard, F. et al. Peripherally administered antibodies against amyloid \u03b2-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916\u2013919 (2000).","journal-title":"Nature Med."},{"key":"BFnrm2101_CR92","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","volume":"61","author":"JM Orgogozo","year":"2003","unstructured":"Orgogozo, J. M. et al. Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization. Neurology 61, 46\u201354 (2003).","journal-title":"Neurology"},{"key":"BFnrm2101_CR93","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","volume":"38","author":"C Hock","year":"2003","unstructured":"Hock, C. et al. Antibodies against \u03b2-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38, 547\u2013554 (2003). First report of the beneficial effects of A\u03b2 immunotherapy in a small cohort of vaccinated patients with AD.","journal-title":"Neuron"},{"key":"BFnrm2101_CR94","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman, S. et al. Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64, 1553\u20131562 (2005).","journal-title":"Neurology"},{"key":"BFnrm2101_CR95","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JA Nicoll","year":"2003","unstructured":"Nicoll, J. A. et al. Neuropathology of human Alzheimer disease after immunization with amyloid-\u03b2 peptide: a case report. Nature Med. 9, 448\u2013452 (2003). First report of the apparent removal of A\u03b2 deposits in humans by a therapeutic agent.","journal-title":"Nature Med."},{"key":"BFnrm2101_CR96","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","volume":"169","author":"RL Patton","year":"2006","unstructured":"Patton, R. L. et al. Amyloid-\u03b2 peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am. J. Pathol. 169, 1048\u20131063 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnrm2101_CR97","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H. & LaFerla, F. M. A\u03b2 immunotherapy leads to clearance of early, but not late, hyperphosphorylated \u03c4 aggregates via the proteasome. Neuron 43, 321\u2013332 (2004). Further evidence of a linear connection between A\u03b2 deposition and tau hyperphosphorylation in an animal model.","journal-title":"Neuron"},{"key":"BFnrm2101_CR98","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M. & Holtzman, D. M. Brain to plasma amyloid-\u03b2 efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264\u20132267 (2002).","journal-title":"Science"},{"key":"BFnrm2101_CR99","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn842","volume":"5","author":"JC Dodart","year":"2002","unstructured":"Dodart, J. C. et al. Immunization reverses memory deficits without reducing brain A\u03b2 burden in Alzheimer's disease model. Nature Neurosci. 5, 452\u2013457 (2002).","journal-title":"Nature Neurosci."},{"key":"BFnrm2101_CR100","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus, C. et al. A \u03b2 peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979\u2013982 (2000).","journal-title":"Nature"},{"key":"BFnrm2101_CR101","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1073\/pnas.0404866101","volume":"101","author":"DS Gelinas","year":"2004","unstructured":"Gelinas, D. S., DaSilva, K., Fenili, D., St George-Hyslop, P. & McLaurin, J. Immunotherapy for Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 14657\u201314662 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR102","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","volume":"43","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe, D. J. & Schenk, D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545\u2013584 (2003).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnrm2101_CR103","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm790","volume":"8","author":"J McLaurin","year":"2002","unstructured":"McLaurin, J. et al. Therapeutically effective antibodies against amyloid-\u03b2 peptide target amyloid-\u03b2 residues 4\u201310 and inhibit cytotoxicity and fibrillogenesis. Nature Med. 8, 1263\u20131269 (2002). Important mechanistic insights about how A\u03b2 immunotherapy can prevent oligomerization and cytotoxicity.","journal-title":"Nature Med."},{"key":"BFnrm2101_CR104","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1073\/pnas.93.1.452","volume":"93","author":"B Solomon","year":"1996","unstructured":"Solomon, B., Koppel, R., Hanan, E. & Katzav, T. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer \u03b2-amyloid peptide. Proc. Natl Acad. Sci. USA 93, 452\u2013455 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR105","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu, W. Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2- protein by degradation. J. Biol. Chem. 273, 32730\u201332738 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR106","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1523\/JNEUROSCI.20-11-03937.2000","volume":"20","author":"HM Tucker","year":"2000","unstructured":"Tucker, H. M. et al. The plasmin system is induced by and degrades amyloid-\u03b2 aggregates. J. Neurosci. 20, 3937\u20133946 (2000).","journal-title":"J. Neurosci."},{"key":"BFnrm2101_CR107","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","volume":"51","author":"S Mueller-Steiner","year":"2006","unstructured":"Mueller-Steiner, S. et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51, 703\u2013714 (2006).","journal-title":"Neuron"},{"key":"BFnrm2101_CR108","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/72237","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata, N. et al. Identification of the major A\u03b21\u201342-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nature Med. 6, 143\u2013150 (2000).","journal-title":"Nature Med."},{"key":"BFnrm2101_CR109","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring, M. A. et al. Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40, 1087\u20131093 (2003).","journal-title":"Neuron"},{"key":"BFnrm2101_CR110","doi-asserted-by":"publisher","first-page":"17941","DOI":"10.1074\/jbc.M601372200","volume":"281","author":"SM Huang","year":"2006","unstructured":"Huang, S. M. et al. Neprilysin-sensitive synapse-associated A\u03b2 oligomers impair neuronal plasticity and cognitive function. J. Biol. Chem. 281, 17941\u201317951 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR111","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1046\/j.1432-1327.1999.00957.x","volume":"266","author":"J McLaurin","year":"1999","unstructured":"McLaurin, J., Franklin, T., Zhang, X., Deng, J. & Fraser, P. E. Interactions of Alzheimer amyloid-\u03b2 peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur. J. Biochem. 266, 1101\u20131110 (1999).","journal-title":"Eur. J. Biochem."},{"key":"BFnrm2101_CR112","doi-asserted-by":"publisher","first-page":"18495","DOI":"10.1074\/jbc.M906994199","volume":"275","author":"J McLaurin","year":"2000","unstructured":"McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P. & Fraser, P. E. Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid \u03b2 peptide and inhibit a\u03b2-induced toxicity. J. Biol. Chem. 275, 18495\u201318502 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR113","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nm1423","volume":"12","author":"J McLaurin","year":"2006","unstructured":"McLaurin, J. et al. Cyclohexanehexol inhibitors of A\u03b2 aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nature Med. 12, 801\u2013808 (2006). New A\u03b2-aggregation inhibitors show beneficial effects on plaque burden and behaviour in mice.","journal-title":"Nature Med."},{"key":"BFnrm2101_CR114","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen, S. et al. A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature 414, 212\u2013216 (2001). Discovery of certain NSAIDs as \u03b3-secretase modulators: they lead to shorter, less amyloidogenic A\u03b2 species.","journal-title":"Nature"},{"key":"BFnrm2101_CR115","doi-asserted-by":"publisher","first-page":"9312","DOI":"10.1073\/pnas.161102498","volume":"98","author":"P Doerfler","year":"2001","unstructured":"Doerfler, P., Shearman, M. S. & Perlmutter, R. M. Presenilin-dependent \u03b3-secretase activity modulates thymocyte development. Proc. Natl Acad. Sci. USA 98, 9312\u20139317 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrm2101_CR116","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/embo-reports\/kvf124","volume":"3","author":"A Geling","year":"2002","unstructured":"Geling, A., Steiner, H., Willem, M., Bally-Cuif, L. & Haass, C. A \u03b3-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 3, 688\u2013694 (2002).","journal-title":"EMBO Rep."},{"key":"BFnrm2101_CR117","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner, D. et al. Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864\u2013870 (1996).","journal-title":"Nature Med."},{"key":"BFnrm2101_CR118","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.8191290","volume":"264","author":"N Suzuki","year":"1994","unstructured":"Suzuki, N. et al. An increased percentage of long amyloid \u03b2-protein secreted by familial amyloid \u03b2-protein precursor (\u03b2APP717) mutants. Science 264, 1336\u20131340 (1994).","journal-title":"Science"},{"key":"BFnrm2101_CR119","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0021-9258(18)48529-8","volume":"267","author":"D Burdick","year":"1992","unstructured":"Burdick, D. et al. Assembly and aggregation properties of synthetic Alzheimer's A4\/\u03b2 amyloid peptide analogs. J. Biol. Chem. 267, 546\u2013554 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR120","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett, J. T., Berger, E. P. & Lansbury, P. T. Jr. The carboxy terminus of the \u03b2-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693\u20134697 (1993).","journal-title":"Biochemistry"},{"key":"BFnrm2101_CR121","doi-asserted-by":"publisher","first-page":"24414","DOI":"10.1074\/jbc.M602363200","volume":"281","author":"YR Chen","year":"2006","unstructured":"Chen, Y. R. & Glabe, C. G. Distinct early folding and aggregation properties of Alzheimer amyloid-\u03b2 peptides A\u03b240 and A\u03b242: stable trimer or tetramer formation by A\u03b242. J. Biol. Chem. 281, 24414\u201324422 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrm2101_CR122","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced A\u03b2 protofibril formation. Nature Neurosci. 4, 887\u2013893 (2001). A genetic explanation for the development of rare forms of AD that is strongly supportive of the amyloid hypothesis.","journal-title":"Nature Neurosci."},{"key":"BFnrm2101_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo, T. et al. Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A \u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43). Neuron 13, 45\u201353 (1994).","journal-title":"Neuron"},{"key":"BFnrm2101_CR124","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1126\/science.8424174","volume":"259","author":"XD Cai","year":"1993","unstructured":"Cai, X. D., Golde, T. E. & Younkin, S. G. Release of excess amyloid \u03b2 protein from a mutant amyloid \u03b2 protein precursor. Science 259, 514\u2013516 (1993).","journal-title":"Science"},{"key":"BFnrm2101_CR125","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron, M. et al. Mutation of the \u03b2-amyloid precursor protein in familial Alzheimer's disease increases \u03b2-protein production. Nature 360, 672\u2013674 (1992).","journal-title":"Nature"},{"key":"BFnrm2101_CR126","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nature Genet. 38, 24\u201326 (2006).","journal-title":"Nature Genet."},{"key":"BFnrm2101_CR127","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. \u03b1-Synuclein locus triplication causes Parkinson's disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"BFnrm2101_CR128","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan, E. et al. A\u03b242 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191\u2013199 (2005).","journal-title":"Neuron"},{"key":"BFnrm2101_CR129","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"M Bentahir","year":"2006","unstructured":"Bentahir, M. et al. Presenilin clinical mutations can affect \u03b3-secretase activity by different mechanisms. J. Neurochem. 96, 732\u2013742 (2006).","journal-title":"J. Neurochem."},{"key":"BFnrm2101_CR130","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1523\/JNEUROSCI.5384-05.2006","volume":"26","author":"Y Deng","year":"2006","unstructured":"Deng, Y. et al. Deletion of presenilin 1 hydrophilic loop sequence leads to impaired \u03b3-secretase activity and exacerbated amyloid pathology. J. Neurosci. 26, 3845\u20133854 (2006).","journal-title":"J. Neurosci."}],"container-title":["Nature Reviews Molecular Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrm2101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrm2101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrm2101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:53:52Z","timestamp":1684454032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrm2101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BFnrm2101"],"URL":"https:\/\/doi.org\/10.1038\/nrm2101","relation":{},"ISSN":["1471-0072","1471-0080"],"issn-type":[{"value":"1471-0072","type":"print"},{"value":"1471-0080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}